Diversity and evolutionary genetics of the three major Plasmodium vivax merozoite genes participating in reticulocyte invasion in southern Mexico by Lilia González-Cerón et al.
RESEARCH Open Access
Diversity and evolutionary genetics of the
three major Plasmodium vivax merozoite
genes participating in reticulocyte invasion
in southern Mexico
Lilia González-Cerón1*, Rene Cerritos2, Jordán Corzo-Mancilla1 and Frida Santillán1
Abstract
Background: Reported malaria cases in the Americas had been reduced to about one-half million by 2012. To
advance towards elimination of this disease, it is necessary to gain insights into how the malaria parasite is
evolving, including the emergence, spread and persistence of new haplotypes in affected regions. In here, the
genetic diversity of the three major P. vivax merozoite genes was analyzed.
Methods: From P. vivax-infected blood samples obtained in southern Mexico (SMX) during 2006–2007, nucleotide
sequences were achieved for: the 42 kDa carboxyl fragment of the merozoite surface protein-1 (msp142), domains
I-II of the apical membrane antigen-1 (ama1I-II), and domain II of the Duffy binding protein (dbpII). Gene
polymorphism was examined and haplotype networks were developed to depict parasite relationships in SMX.
Then genetic diversity, recombination and natural selection were analyzed and the degree of differentiation was
determined as FST values.
Results: The diversity of P. vivax merozoite genes in SMX was less than that of parasites from other geographic
origins, with dbpII < ama1I-II <msp142. Ama1I-II and msp142 exposed the more numerous haplotypes exclusive to
SMX. While, all dbpII haplotypes from SMX were separated from one to three mutational steps, the networks of
ama1I-II and msp142 were more complex; loops and numerous mutational steps were evidenced, likely due to
recombination. Sings of local diversification were more evident for msp142. Sixteen combined haplotypes were
determined; one of these haplotypes not detected in 2006 was highly frequent in 2007. The Rm value was higher
for msp142 than for ama1I-II, being insignificant for dbpII. The dN-dS value was highly significant for ama1I-II and
lesser so for dbpII. The FST values were higher for dbpII than msp142, and very low for ama1I-II.
Conclusions: In SMX, P. vivax ama1I-II, dbpII and msp142 demonstrated limited diversity, and exhibited a differentiated
parasite population. The results suggest that differential intensities of selective forces are operating on these gene
fragments, and probably related to their timing, length of exposure and function during reticulocyte adhesion and
invasion. Therefore, these finding are essential for mono and multivalent vaccine development and for epidemiological
surveillance.
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Background
Plasmodium vivax is the main species causing malaria in
the Middle East, Asia, the West Pacific, and Central and
South America, where billions of people are at risk [1, 2].
In the Americas, the number of malaria cases gradually
declined from 2000 to 2012 due to the improvement and
intensification of control measures. In 2012, 469,369 new
malaria cases were reported, which represents a 72 % re-
duction compared to the year 2000 [3, 4]. In 2008, 20,833
cases were reported in Mesoamerica (from Southern
Mexico to Panama), of which 11.3 % corresponded to
Mexico. Around the world there are countries that have
advanced to the pre-elimination phase, while others have
reported little decline or even an increase in the number
of malaria cases [5, 6]. To contribute to better control ef-
forts and accelerate malaria elimination, more knowledge
is needed about the parasites circulating in each region. In
this sense, analysis of the evolutionary forces that shape
malaria antigen diversity can be useful for monitoring and
designing vaccines, describing transmission dynamics, and
conducting epidemiological surveillance.
The Plasmodium merozoite invades reticulocytes in a
few seconds by a series of complex interactions. The mer-
ozoite surface protein 1 (MSP1) participates in the initial
adhesion to the reticulocyte and the apical membrane
antigen 1 (AMA1) into parasite reorientation [7–9]. Then
the Duffy binding protein (DBP) irreversible binds at the
time of reticulocyte invasion [10]. In P. vivax the MSP1 of
200 kb is coded by a gene located in chromosome 7 and is
comprised of variable and semi-conserved blocks. This
protein is processed into fragments of 83, 30, 38 and
42 kDa [11]. At the time of invasion, the carboxyl frag-
ment of 42 kDa is further processed into two fragments of
33 and 19 kDa (MSP133 and MSP119). Both fragments are
immunogenic, capable of inducing antibodies that block
merozoite invasion [12]. AMA1 is an antigen of 66 kDa,
coded by a gene located in chromosome 9 and secreted by
micronemes. The ecto-cytoplasmic region is comprised of
three domains (I, II and III) and 16 cysteine residues [13].
The crystal structure of AMA1 shows that domains I and
II have a structure similar to the PAN adhesive motive
and participate in reticulocyte adhesion, and that domain
I is more variable than domain II [8]. DBP is an integral
membrane protein of 140 kDa coded by a gene located in
chromosome 6 and comprised of seven domains: a signal
peptide, two cysteine-rich domains flanking the amino
N-cys and carboxyl C-cys (II and VI), three hydrophobic
domains (III - V) and one trans-membrane domain (VII)
[14]. Domain II (DBPII), which comprises 170 amino acids
flanked by cisterns 4 and 7 (within residues 291 and 460),
binds the Duffy antigen on the reticulocyte surface. This
domain also presents high molecular polymorphism, but
the precise site of interaction seems to be more conserved
[14, 15]. These merozoite proteins induce antibodies
capable of blocking reticulocyte invasion. MSP1 seems to
be the most immunogenic, evidenced by the fact that a
large number of patients developed antibodies against it
after the primary blood infection [16, 17]. Apparently,
AMA1 is the second most immunogenic [18, 19] and
DBP the least [20, 21].
In southern Mexico, previous studies have shown that
P. vivax comprises a unique genetic population, such as
the association of vector compatibility to Pvs25-28 protein
polymorphisms [22] and to subpopulations defined by
microsatellite markers [23]. By analysis of msp1 block
icb5-6 from this region, divergent lineages of Sal 1 or
Belem strains were distinguished [24]. To gain further in-
sights into the evolutionary genetics of P. vivax merozoite
vaccine candidates, the genetic diversity of ama1I-II, dbpII
and msp142 fragments was analyzed in parasites from
southern Mexico and compared to other geographic
origins.
Methods
This study was approved by the Ethics Committee of
the National Institute of Public Health in Mexico
(INSP, according to the initials in Spanish). Informed
consent was obtained from all adult patients and the
guardians of minors.
The specific area of southern Mexico herein studied is
its Pacific coastal plain, defined as Jurisdiction VII of the
State of Chiapas. This jurisdiction comprises 4644.07 km2
and during the period of the present study (2006–2007)
had a population of 710,716 inhabitants. Its altitude ranges
from sea level to mountainous regions of about 4000 m
above sea level, and has a great climactic and biological
diversity. In the State of Chiapas, malaria transmission has
been persistent but fluctuating. Since the 1980’s, when
over 20, 000 cases were reported per year, malaria trans-
mission has been declining. In the late 1990’s, there were
about 1000 cases reported per year [25]. In Jurisdiction
VII of the Chiapas State only 167 cases were reported in
2005. After hurricane Stan hit the region in October of
2005, the anti-malarial brigades did not have access to the
affected areas for at least four months. As a result, the
number of malaria cases increased in 2006 to 646 and in
2007 to 644 (data from the local malaria control program,
Sanitary Jurisdiction VII).
P. vivax blood samples
During 2006 and 2007, malaria symptomatic patients
living in Jurisdiction VII and diagnosed with P. vivax
infection by microscopy were invited to donate 5 ml
of venous blood. The DNA from infected blood samples
was extracted using a commercially available QIAamp
DNA blood minikit (Qiagen, USA), following the manu-
facturer’s instructions. From 200 μL of heparinized
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infected blood, two hundred microliters of soluble DNA
were obtained.
PCR amplification and DNA sequencing
The msp142 gene fragment of approximately 1.2 kb was
amplified using primers msp1-5´AAGCTTAGAGGACTA
CGACAAAG -3' and msp1-3´GTCGAAGGATTCGAAC
GAGCTCG 5'. The PCR was prepared as follows: 60 mM
de Tris-SO4, 18 mM ammonium sulphate, 2 mM of
MgSO4, 0.2 mM of dNTPs, 0.4 μM of each primer, 1U
Platinum Taq DNA polymerase High Fidelity (Invitrogen,
Carlsbad, CA) and 1–4 μL of genomic DNA, for a final
PCR volume of 50 μL. The reaction was run at 95 °C
for 5 min, followed by 35 cycles of 95 °C for 60 s,
60 °C for 60 s and 72 °C for 75 s, and a final exten-
sion at 72 °C for 10 min.
The ama1 I-II gene fragment of approximately 1.1 kb
was amplified using primers ama1f-5'-TCCAGCTGGAA
GATGTCCTG-3' and ama1r-5'-CCGCCCTTTTCTCTA
CACAG-3'. The PCR was prepared as aforementioned
and the reaction was run at 95 °C for 5 min, followed by
35 cycles of 95 °C for 60 s, 61 °C for 60 s and 72 °C for
75 s, and a final extension at 72 °C for 10 min.
The dbpII gene fragment of approximately 1.2 kb was
amplified by polymerase chain reaction (PCR) using the
following primers: dbpf-5' GATAAAACTGGGGAGGAA
AAAGAT 3' and dbpr-5' CTTATCGGATTTGAATTG
GTGGC 3'. The PCR was prepared as aforementioned
and the reaction was run at 94 °C for 3 min, followed by
35 cycles of 94 °C for 40 s, 58 °C for 40 s and 72 °C for
1.5 min, and a final extension at 72 °C for 5 min.
The amplified products were examined in agarose gels
at 1 % and stained with 0.2 μg/ml ethidium bromide using
a Midicell primo electrophoresis chamber (Thermo
EC330, New York, USA). The 100 bp ladder was used as a
molecular marker (Invitrogen Corporation, Carlsbad, CA).
The gel image was obtained in a photo documentation
UV system (LMS-20E Bio-Doc-it, Upland, CA).
The amplified products, estimated by visual observation,
were purified using a MinElute PCR purification kit
(Qiagen, Valencia, CA), following the manufacturer’s in-
structions. The purified products were sequenced using
forward and reverse primers for merozoite genes in a Taq
FS Dye Terminator Cycle Fluorescence-Based Sequencer
(Perkin Elmer/Applied Biosystems Model 3730) at the
Biotechnology Institute of the National Autonomous
University of Mexico at Cuernavaca (Morelos, Mexico).
The quality of pherograms with the forward and re-
verse nucleotide sequences was verified manually and
by using Bioedit v7.1.3 software. Consensus sequences
were obtained for each gene fragment and were sub-
mitted to the NCBI GenBank [accession numbers:
KP759780–KP759884].
Data analysis
The consensus sequences were aligned to the correspond-
ing reference gene strains Sal 1 and Belem, respectively, as
follows: for dbpII, XM_001608337.1 and EU395587; for
ama1I-II, XM_001615397 and EU395595; for msp142,
XM_001614792.1 and AF435594. DNA polymorphism
was analyzed for the three gene fragments. The number of
segregating sites (polymorphic) (S), number of mutations
or nucleotide changes (M), number of haplotypes (H),
haplotype diversity (Hd), nucleotide and genetic diversity
(Pi; π, Theta; θ), and their corresponding standard devia-
tions (SD) were calculated with DnaSP v5.1 software [26].
Haplotype frequencies for each gene fragment and for
combined haplotypes were examined over time.
To explore the genetic relationship between the haplo-
types of each merozoite gene, and how these haplotypes
show up in the parasite isolates, a minimum spanning
haplotype network was constructed for each gene frag-
ment using TCS 1.21 [27] and Median Joining Network
in PopArt 1.7 [28].
To determine how selective forces influence the haplo-
type relationship, the minimum number of recombination
events (Rm) was estimated by the four-gamete test [29].
D’ and R2 indexes of linkage disequilibrium were deter-
mined by non-random association between nucleotide
variants within the gene fragments using DnaSP. To test
the neutral theory of evolution, Tajima’s D values were
calculated. Positive values correspond to positive or balan-
cing selection, whereas negative values correspond to
negative or purifying selection [30]. In coding regions, an
excess of non-synonymous relative to synonymous
changes is a clear signal of positive selection. Different
levels of positive selection have been reported in other
geographic sites for msp142 [31–33], ama1I-II [13, 34] and
dbpII [35, 36]. Hence, the dN-dS difference between the
rate of the average number of non-synonymous (dN) and
synonymous (dS) nucleotide changes was calculated for
each gene fragment of the distinct parasite groups by
using the alternate hypothesis (HA: dN > dS). For this
purpose, we used Nei-Gojobori’s method [37] and
bootstrap variance estimation with 1000 replicates for
the Z-test of selection (p < 0.05) in MEGA v6.0 soft-
ware [38].
Finally, Wright’s fixation statistics (FST) [39] indexes
were calculated to determine the degree of differenti-
ation of P. vivax in southern Mexico based on each
merozoite gene (dbpII, msp142 and ama1I-II), using
DNA sequences of parasites from different geographic
origins, by using the model of two parameters of
Kimura 2P in DnaSP [26, 40]. FST values range from
0 to 1, high values indicate considerable degree of dif-
ferentiation between parasite populations.
Homologous DNA sequences from other geographic
sites were obtained from the NCBI GenBank: Msp142.
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For South Korea (SK), n = 200: JQ446312-JQ446322 [41],
HQ171934-HQ171941 [42], and AF435635-AF435638
[11]. For Turkey (TUR), n = 30: AB564559-AB564588 [43].
For Thailand (THL), n = 93: AF435595-AF435615 [11],
GQ890917-GQ890974 [44], AF199393- AF199404, and
AF199408- AF199410 [45]. For Singapore (SNG), n = 50:
GU971656-GU971705 [46]. For India-Bangladesh (IND-
BNG), n = 35: EU430452-EU430479 [31], KF612323 [47],
AF435639, and AF435616-AF435620 [11]. For Brazil (BRZ),
n = 11: AF435622-25, 27, 29, 30, 31,[11] and AF199405-7
[45]. For Sri Lanka (SLK), n = 106: AJ292349-AJ292359
and GU175174-GU175268 [32]. For Myanmar (MYN),
n = 28: JX490129-JX490156 (Zhou and Chen, unpublished).
For Cambodia (CAM), n = 44: JX461286-JX461310,
JX461312, JX461313, and JX461315- JX461332 [48].
Ama1I-II: For THL, n = 231: FJ784891-FJ785121 [49]. For
Venezuela (VNZ), n = 73: EU346015-EU346087 [34]. For
IND, n = 56: EF025187-EF025197 [50] and EU282774-
EU282822 [51]. For SLK, n = 23: EF218679-EF218701
[13]. For Iran (IRN), n = 83: JX624732-35 [52], KF422636-
681, and KF422636-KF422681 [53]. For Papua New
Guinea (PNG), n = 102: KC702402-KC702503 [54]. DbpII:
For MYN, n = 54: JN255576-JN255587 [55]. For SK
n = 111: JN989472-JN989484 [56], AF215737-AF215738
[57], AF220657-AF220663, AF220668 [58], DQ156522,
DQ156523, and DQ156515 (Lim and Ayala, unpublished).
For PNG, n = 201: AF289480-AF289483, AF289635-
AF289640, AF289642-AF289645, AF289647-AF289653,
AF291096 [59], AF469515-AF469602 [60], AY970837-
AY970925 [61], and DQ156519 (Lim and Ayala, unpub-
lished). For THL, n = 30: EF219451, EF368159-EF368180,
EF379127, EF379128, and EF379130-EF379134 [35]. For
BRZ, n = 122: EU812839-EU812960 [62]. For IND, n = 95:
DQ156514, DQ156516 (Lim and Ayala, unpublished),
FJ491142-FJ491144, FJ491146-FJ491161, FJ491163-FJ491169,
FJ491171-FJ491173, FJ491175-FJ491218, FJ491221-FJ491234,
and FJ491236-FJ491241 (Prajapati and Joshi, unpublished).
For Colombia (COL), n= 17: U50575-U50591 [63]. For SLK,
n= 100: GU143914-GU144013 [64]. For IRN, n= 130:
EU860430-EU86038 [65], KF318358, KF318359 KF791921,
and KF791923-KF791926 [66].
Results
Genetic polymorphism of P. vivax merozoite genes in
SMX
From 35 P. vivax isolates (2006, n = 17; 2007, n = 18), gene
fragments dbpII, ama1I-II and msp142 were amplified and
the consensus nucleotide sequence obtained. Although
several P. vivax isolates had codons or nucleotide
fragments that resembled either Sal 1 or Belem, none
was identical to either of these sequences. The
msp142 sequence was more polymorphic than that of
dbpII or ama1I-II (Table 1).
The msp142 gene fragment of 1072 bp (codons
1353–1710) had 52 polymorphic sites, in which 59
nucleotide changes were detected. All nucleotide changes
were detected in subfragment msp133 (nucleotides
4060–4875), and five of these were synonymous. Subfrag-
ment msp119 was conserved (Table 1; Additional file 1).
Nine haplotypes were resolved and the haplotype diversity
(Hd) was higher than that found for dbpII.
Fourteen polymorphic sites and seven haplotypes were
detected among the 35 isolates for the ama1I-II gene
fragment of 885 bp (Table 1). Domain I had 11 nucleotide
changes (within codons 125–243) and domain II three
(within codons 244–460). Compared to the Sal 1 se-
quence, three additional polymorphisms were detected,
with one synonymous change at codon 137 Pro (cca→
ccc), and two nonsynonymous changes at codons 145
Glu/Ala (gaa→ gca) and 277 Glu/Lys (gag→ aag). These
variant codons resembled the sequence of the Belem
strain (Additional file 2).
A gene fragment of 1,104 pb was obtained for dbpII.
Fourteen polymorphic sites and mutations were detected
within codons 191–558. The only synonymous change, at
codon 530 (aac→ aat), was found in two isolates. Most of
the diversity indexes were lower than those estimated for
ama1I-II and msp142 (Table 1; Additional file 3).
Temporal distribution of single and combined haplotypes
P. vivax haplotypes were detected at a different frequency
over time (Fig. 1; Additional file 4). The highest number
of haplotypes for all three gene fragments (dbpII, ama1I-II
and msp142) was found in 2006, when all eight dbpII and
seven of the ama1I-II haplotypes were detected. Mean-
while, only three dbpII and four ama1I-II haplotypes were
identified in 2007. For msp142, eight of nine total haplo-
types were detected in 2006. In addition, of 16 combined
haplotypes (dbpII-ama1I-II-msp142), 13 were detected in
2006 and seven in 2007 (four of them were found in both
years). For the three haplotypes exclusively detected in
2007, haplotype A was significantly more frequent (59 %)
than the others (p = 0.00024) and was detected from
January to September.
Haplotype relationships for different merozoite genes and
the haplotype configuration for P. vivax isolates in SMX
Each gene fragment produced a haplotype network with
a different pattern (Fig. 2). 1) The SMX dbpII network
was the simplest; the haplotypes were separated by one
to three mutational steps. From a highly frequent haplo-
type (dh1; 65.7 %), two branches emerged, and the most
distant haplotypes (dh3 or dh4) were separated in opposite
directions by eight and eleven mutational steps, respect-
ively. Rather than a network, a straight-line pattern was ob-
served. 2) For SMX ama1I-II, the highly frequent haplotype
(ah1; 45.7 %) and another four formed a loop, with 3 - 5
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mutational steps in between. From haplotype ah5 there was
a branch connecting more divergent haplotypes, ah2 and
ah6. 3) The SMX msp142 network was more complex than
that of ama1I-II. Several haplotypes (mh2, mh3 and mh5)
were apparently separated from the most frequent haplo-
type (mh1; 40 %) by numerous mutational steps. The
triangle-like structures suggest the presence of different
selective forces. Sign of local divergence was detected in all
three gene fragments, and it was more apparent in msp142.
Haplotypes mh6, mh7 and mh8 seemed to have appeared
by a mutation from other more frequent haplotypes. Haplo-
type mh6 had a nonsynonymous change exclusive to
SMX at codon 1625 Lys/Glu (aag→ gag). A total of 16
different dbpII - ama1I-II - msp142 haplotype arrangements
were displayed (indicated by colors in Fig. 2). That is,
P. vivax isolates with haplotype dbpII dh1 could be accom-
panied by different and highly divergent ama1I-II and
msp142 haplotypes; for example, ah1, ah2, ah3 or ah6, and
mh2, mh3 or mh5 and so on.
Recombination and linkage disequilibrium
Rm values were higher for msp142 than ama1I-II and dbpII
(Table 2). All three gene markers were under linkage
disequilibrium, with D’ values polarized to the upper and
lower sides of the graph (−1.0 or 1.0). For msp142, a set of
values ranged from 0.5 to −0.25, and the R2 regression line
started from ~0.35 (the lowest value for the three gene
fragments) and decreased slowly with nucleotide distance.
The graph shows the significant values of Fisher’s
exact test; 203 significant comparisons were detected
using the Bonferroni correction; R2 values were above
0.5. For dbpII, R
2 regression started at ~0.58 and
sharply decreased to zero; with the Bonferroni correc-
tion only 18 comparisons were significant; R2 values
were above 0.45. For ama1I-II, on the other hand, the
R2 regression line showed a subtle increase across the
nucleotide distance; 74 significant comparisons were
found with the Bonferroni correction; R2 values were
above 0.378 (Fig. 3).
Table 1 Comparison of P. vivax merozoite gene diversity among isolates from southern Mexico, 2006–2007
Parameter Gene fragment
msp142 ama1I-II dbpII
bp 1071 885 1104
1n, polymorphic sites 52 14 14
n, nucleotide changes 59 14 14
2π (SD) 0.01716 (0.00179) 0.00745 (0.00039) 0.00304 (0.00062)
3Θw (SD; nr, fr) 0.01178 (0.00381, 0.00163) 0.00384 (0.00150, 0.00103) 0.00308 (0.00120, 0.00082)
n, haplotypes 9 7 8
4Hd (SD) 0.783 (0.051) 0.723 (0.057) 0.556 (0.094)
Tajima’s D test (P value) 1.0408 (>0.10) 3.0416 (<0.01) - 0.0459 (>0.10)

















Fig. 1 Monthly distribution of P. vivax dbpII - ama1I-II - msp142 combined haplotypes in southern Mexico, 2006–2007. Each haplotype is indicated
by a different color. Of 16 combined haplotypes, 13 were detected in 2006 and seven in 2007. Four were common to both years, while nine were
exclusive to 2006 and three to 2007. The most frequent combined haplotype (in green) was only detected during 2007
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Natural selection
Tajima’s D value was positive for msp142 and ama1I-II,
although statistical significance existed only for ama1I-II.
The value for dbpII was near neutrality (Table 1). For all
gene fragments, non-synonymous nucleotide changes
were more numerous than synonymous ones, and dN-dS
values were consistently above 1.0 (Table 2). Unlike
msp142, highly significant dN-dS values were detected
for ama1I-II and dbpII.
Genetic comparison of P. vivax merozoite genes from SMX
to other geographic sites
In SMX, the highest nucleotide diversity (π) was for
msp142, followed by ama1I-II and finally dbpII (Table 1).
Fig. 2 Haplotype networks of P. vivax genes encoding merozoite surface proteins in southern Mexico, 2006–2007. The haplotype network for each gene
marker is shown. Each circle represents one haplotype and the circle size indicates frequency. The mutational steps are indicated by the short marks
crossing the connection lines. Each color indicates a particular combined haplotype (dbpII- ama1I-II-msp14, n= 16; coded by letters A→ P). For example,
isolates in dark green had the combined haplotype dh1-ah1-mh1, which was highly frequent and only detected in 2007. Meanwhile, isolates in intense
pink and orange had a very different configuration (dh1, ah2 and mh3 or mh5), and haplotypes G, N, O and P had a distinctive and unique configuration
Table 2 Natural selection and recombination of P. vivax genes encoding merozoite proteins
Merozoite gene
fragment
Geographic origin N dN-dS Recombination Rm
*Synonymous *Non-synonymous Z-test p
msp142 SMX 35 6 34 1.276 0.102 9
Global 632 21 88 2.755 0.007 22
ama1I-II SMX 35 1 13 2.157 0.016 3
Global 607 15 36 1.562 0.121 17
dbpII SMX 35 0 10 3.161 0.001 1
Global 896 34 125 2.587 0.005 18
SMX, southern Mexico; N, number of sequences; Rm, minimal number of recombination events. msp142, 981pb; ama1I-II, 780pb; dbpII, 663pb. *Codons with multiple
evolutionary paths were excluded from the analysis
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The genetic and nucleotide diversity for SMX msp142
was lower than that found in all other sites (e.g., BRZ,
IND and MYN) except TUR and SK (Additional file 5a).
Similarly, the nucleotide diversity of SMX ama1I-II was
lower than that for all other locations except VNZ
(Additional file 5b), while the SMX dbpII fragment
showed the lowest diversity of all locations (Additional
file 5c). In contrast, Asian parasites were the most
diverse for these three gene markers.
A sample of 35 isolates is acceptable for diversity
analysis [67]. There were similar or smaller samples than
SMX and from high transmission regions and the diversity
results were as high as expected (e.g. BRZ, IND and MYN
for msp142; THL, IND and SLK for ama1I-II; COL and
THL for dbpII) (Additional file 5). There were differences
in the number of exclusive haplotypes detected in each
gene fragment; msp142 and ama1I-II > dbpII (Additional




Fig. 3 Linkage disequilibrium (D’ and R2 indexes) in P. vivax merozoite gene fragments: a) msp142, b) ama1I-II and c) dbpII. Significant D’ values for
all gene fragments were mostly polarized to the upper and lower range (from −1.0 to 1.0), except in msp142. R
2 values were high and diminished
with nucleotide distance in dbpII and msp142, while remaining high in ama1I-II. Circles in grey indicate a significant non-random association between
nucleotide variants at different polymorphic sites, according to Fisher’s exact test at a 95 % confidence level
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very frequent ones) were shared with BRZ and sites
outside the Americas. Two ama1I-II haplotypes were
only detected in VNZ (ah3 and ah4). Meanwhile, the
most abundant msp142 (mh1) haplotype was also de-
tected in BRZ, TUR and SK, and mh3 was also found
in THL. Haplotype mh6 was only detected in one iso-
late and had one nonsynonymous change exclusive for
SMX.
The Rm value of nine found for SMX msp142 was
slightly lower than the range of 10 to 13 calculated for
other locations (SLK was the exception, with a value of
23; Additional file 7). Similarly, Rm values for ama1I-II
and dbpII (three and one, respectively) were significantly
lower in SMX than those found for other locations
(ranging from six to eleven, p = 0.0008, and from five
to ten, p = 0.0003, respectively; Additional file 7).
Similar to SMX, a significant positive dN-dS was
detected in P. vivax ama1I-II from VNZ, PNG and SLK,
but this parameter was not significant for IRN or IND
parasites. Globally, positive selection was not significant
(Table 2). However, this lack of significance may be due
to the low value (0.368; p = 0.357) and large sample size
(231 isolates) of THL parasites (Additional file 7).
Indeed, the global analysis without THL resulted in a
significantly positive dN-dS value (2.291, p = 0.012). For
msp142 of P. vivax parasites, this parameter had a signifi-
cant positive value in most countries, except SMX, TUR
and BRZ, and to a lesser extent SLK (Additional file 7).
Genetic differentiation of P. vivax based on merozoite
gene markers
FST values for P. vivax merozoite genes varied between
intra and inter-continental regions, and there was no
relation to geographic origin (Table 3). For msp142, FST
values were from 0.0918 to 0.2859 between SMX para-
sites and those of other geographic origins. In fact, the
lowest values were between the parasites of SMX and
those of BRZ, IND-BNG and SLK. Interestingly, the
highest FST values were observed (0.2977–0.5069) be-
tween TUR and other geographic sites, except between
TUR and SMX (the lowest value, 0.1332).
The values for ama1I-II were from 0.0799 to 0.2374
between SMX parasites and those of other geographic
origins. The lowest value was between SMX and IRN,
while the highest values were found when comparing
SMX or VNZ to PNG. SMX vs THL or VNZ showed
similar values (0.1983 vs 0.1881, respectively). It is
notable that P. vivax dbpII produced high FST values
between SMX and many other locations (0.1767–0.3157).
Strikingly, the highest value was between SMX and COL,
which was greater than that found between SMX and
PNG or SK. The latter results are in agreement with the
values for ama1I-II (between SMX and PNG). The FST
value between SMX and THL was similar for the three
merozoite genes (0.1767–0.1983). Regarding SMX vs
IND-SLK, there were low FST values for ama1I-II
(0.108) and msp142 (0.097), but a higher value for
dbpII (0.247). However, only in SMX were the three
merozoite genes analyzed simultaneously (in the same
parasite sample).
Discussion
In Mexico the problem of malaria transmission has
existed for a long time, and since the 1950’s the number
of cases has been recorded. In the 80’s more than
100,000 cases were reported each year, at which time
malaria was widespread in most of the country. From
2000 onwards, transmission has been gradually decreas-
ing, now reduced to residual foci. Presumably, this is
due to vector control, case detection and drug delivery
[68]. In the last decade, Mexico has advanced to the pre-
elimination phase [69]. The remaining P. vivax could
correspond to parasites with genetic and biological char-
acteristics that have allowed them to persistent in the af-
fected regions. In the Americas, the scant information
available on the diversity of the main merozoite vaccine
candidates is fragmented e.g., msp142 [11] and dbpII [62]
from BRZ, ama1I-II from VEN [34], and dbpII from COL
[63].
Figure 4 summarizes the differences between three mer-
ozoite genes of P. vivax in SMX. The present study
evidences limited genetic diversity for msp142 > ama1I-II >
dbpII. This low variation was previously detected for other
makers such as pvs25-28 [22] and the circumsporozoite
gene [70]. Different biological and socioeconomic factors
contribute to the maintenance of certain P. vivax diversity,
including the rate of hypnozoite and asymptomatic blood
infections, early gametocyte development, and the delay in
diagnosis and treatment [71, 72]. These factors were prob-
ably magnified after hurricane Stan devastated the SMX
region. Also, since 1999 in Mexico, malaria medication
has been comprised of single doses of CQ and PQ in an
intermittent monthly scheme. This medication scheme
did not affect the hypnozoite prevalence per se [73, 74].
Therefore, most of the haplotypes detected in 2006 might
correspond to the activation of genetically different
hypnozoites in the region. After antimalarial measures
reached these areas, fewer haplotypes were detected in
2007. Only those whose frequency was favored managed
to prevail.
The haplotype networks arrangement of msp142,
ama1I-II, dbpII suggested the presence of recombination
and local diversification in these gene fragments in
SMX. The greater complexity of the msp142 network
might be due to the high degree of recombination
defined by the Rm value and linkage disequilibrium
indexes. Multiple haplotype configurations were found
in this hypo-endemic region, and probable aggravated
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in other locations with more complex epidemiology and
higher transmission. Such finding evidenced the import-
ance of evaluating the manner that multivalent vaccines
components are evolving in the affected regions.
There is evidence that recombination events occur in
P. vivax during meiotic and mitotic reproduction [32, 36].
Accordingly, it has been described that the mosaic struc-
ture of these merozoite genes resulted from recombin-
ation across the dbpII [75], msp1 [11] and ama1I-II [34]
gene sequences. Even in a low transmission setting, a high
recombination rate for the P. vivax msp1 gene occurs
[11]. In SMX, the results suggest a moderate recombin-
ation rate for msp142in the P. vivax sample. The presence
of mixed genotype infections is a prerequisite for the
generation of new recombinant haplotypes during meiosis
in the mosquito midgut. In SMX, about 5–10 % of mixed
infections were previously detected [23, 73]. Whether or
not msp142 recombinants were generated in SMX, they
prevailed and local diversification probably occurred.
The nucleotide diversity found between SMX P. vivax
merozoite genes and those at other locations could have
been influenced by different historical, epidemiological
and ecological transmission dynamics. For example, in
SLK, with low and unstable transmission, recombination
events in this gene fragment were reportedly numerous
[13, 64, 76]. The chances of generating a recombinant
were higher in SLK than SMX because 69 % of infec-
tions had more than one genotype [77].
Table 3 FST indexes for P. vivax based on merozoite genes; values between southern Mexico and other geographic sites are in bold
amsp142
SMX BRZ TUR SK SNG THL CAM IND-BAN MYN
BRZ 0.1065
TUR 0.1332 0.3554
SK 0.2859 0.2229 0.5069
SNG 0.2370 0.2754 0.4064 0.3221
THL 0.1817 0.1129 0.3803 0.2760 0.1007
CAM 0.1710 0.0806 0.3637 0.2279 0.1366 0.0093
IND-BAN 0.0978 0.0427 0.3074 0.1139 0.1273 0.0476 0.0266
MYN 0.1754 0.0968 0.3596 0.2189 0.0966 −0.0081 −0.0042 0.0192
SLK 0.0918 0.0377 0.2977 0.2099 0.1531 0.0365 0.0374 0.0119 0.0267
bama1I-II
SMX VNZ IRN IND SLK THL
VNZ 0.1881
IRN 0.0799 0.1220
IND 0.1080 0.1395 0.0066
SLK 0.1402 0.1682 0.0830 0.0740
THL 0.1983 0.1580 0.1133 0.0934 0.0850
PNG 0.2374 0.2859 0.1194 0.0803 0.1738 0.1993
cdbpII
SMX COL BRZ IRN IND SLK SK THL MYN
COL 0.3157
BRZ 0.2269 0.1386
IRN 0.2255 0.1812 0.0487
IND 0.2476 0.1640 0.0132 0.0668
SLK 0.2652 0.1755 0.0303 0.0923 0.0260
SK 0.2601 0.2992 0.1327 0.1895 0.1222 0.1263
THL 0.1767 0.1922 0.0616 0.1414 0.0764 0.0873 0.1369
MYN 0.2040 0.2364 0.0840 0.1484 0.0810 0.0982 0.1286 0.0016
PNG 0.2799 0.2057 0.1260 0.1745 0.1483 0.1376 0.2252 0.1205 0.1452
SMX, southern Mexico; IRN, Iran; IND, India; BRZ, Brazil; COL, Colombia; PNG, Papua New Guinea; SLK, Sri Lanka; THL, Thailand; SK, South Korea; MYN, Myanmar;
VNZ, Venezuela; SNG, Singapore; BNG, Bangladesh; TUR, Turkey; CAM, Cambodia
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These merozoite proteins are exposed to the host-
specific immune response, which causes selective pressure
likely results in an evasive parasite response [62, 78, 79].
At least in SMX, recombination events maintain nucleo-
tide diversity in msp142 as a function of immune evasion
and likely counteract the low degree of positive selection.
The latter is evidenced by the lower dN-dS value for
msp142 than for ama1I-II and dbpII. Unlike in SMX, in
most geographic locations the dN-dS value for msp142 was
highly significant.
Because of being processed on the merozoite surface,
MSP1 is presumably more exposed to the immune system
than AMA1 and DBP (Fig. 4). Studies in BRZ have
reported that in response to natural infection, a higher
proportion of individuals had detectable antibodies against
MSP1 than AMA1: 95 vs 72.7 % [78] and 90.5 vs 57 %
[80]. In addition, 58.3 % [79] and 65 % [18] of the antibody
response was reported to be against domain II of AMA1
(AMA1II). On the other hand, DBP is only secreted at the
time of invasion [15], and thus induces a weak and short-
lasting antibody response [62], which in one study was
detected in 44.5 % of primary infected individuals [78]. To
evade the immune response, genes encoding for antigenic
proteins accumulate non-synonymous mutations, which
leads to an increase in diversity. In this study, values of
dN-dS and Tajima’s D suggest that balancing selection
[81] might have maintained the frequency of the amaI-II
haplotype in P. vivax from SMX, as has been suggested
for other geographic sites such as SLK [13], IND [51],
MYN [82], VNZ [34] and Honduras [83]. Patterns of
diversifying selection were also suggested for ama1I-II in
VNZ [34] and COL [75].
Although Tajima’s D value was negative for dbpII in
SMX, no departure from neutrality was evidenced.
Meanwhile, the dN-dS value (3.16) was highly significant
and the absence of recombination may be indicative of a
recent selective sweep. It has been reported that haplo-
type specific immunity existed for DBPII [84]. Residues
N417K, W437R and I503K were involved in antigenic
drift; the resulting variant haplotypes KRK and NRK
evaded antibodies induced by the Sal 1 sequence [14].
This type of polymorphisms are highly frequent at the
global level [85]. In SMX, the haplotype bearing variant
residues KRK was significantly more frequent (85 %).
However, it is unknown whether its transmission was
actually favored by other polymorphisms or by other
genetic and/or biological factors. On the other hand,
because dbpII had the lowest nucleotide diversity, there
were a large number of globally shared, closely related
haplotypes. Hence, this gene fragment may be under
functional and/or structural restrictions, as previously
suggested by others [86] (Fig. 4).
The FST values of the current study indicate that all
merozoite gene fragments evidence a certain degree of
P. vivax genetic differentiation in SMX. Consistently
higher values were obtained for dbpII, which showed
almost no recombination and no significant departure
from neutrality, resulting in little diversity. However, if
antigenic drift was operating in this gene fragment, it
may have rendered few divergent dbpII haplotypes and
biased the FST values. A similar effect was observed for
msp142 in TUR parasites [43]. Notwithstanding, in order
to elucidate P. vivax differentiation and the degree of
gene flow in SMX, it would be necessary to analyze
balancing  
selection 




dbpII Nucleotide diversity increases  
Positive selection: dN-dS values decrease    
Many private Haplotypes  
Immune exposition diminishes? [Ref. 78-80]   
Functional and structural restriction increases? [Ref. 86]    
Recombination increases  
Fig. 4 Summary of the genetic characteristics of P. vivax merozoite genes participating sequentially in erythrocyte invasion in southern Mexico.
The parasite sample was obtained after hurricane Stan caused an increase in P. vivax transmission. MSP142 participates in the initial adhesion to
the reticulocyte, AMA1I-II in re-orientation, and DBPII in the moment that invasion initiates Ref. [7–9]
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mitochondrial markers. The existence of genetic flow
between Central and South American regions, which has
been suggested [87], is an important factor to be taken
into account for malaria control and elimination.
Conclusions
The aforementioned results of the present study pro-
vide insights into merozoite vaccine candidates in
Mesoamerica. Several factors should be considered to
design and monitor monovalent and multivalent
formulates, including the fluctuation of haplotype
frequency, differences in intensity of recombination
and natural selection of vaccine components [88–90].
In addition, the current findings can also facilitate the
establishment of a molecular baseline for epidemiological
surveillance.
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